Cogent Biosciences Inc.

COGT | NASDAQ

Price Alert Chart Builder DCF Calculator

$32.23

+$0.23 (+0.72%)

Sep 22, 2026, 12:45 PM ET · Market open

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Income Statement Balance Sheet Cashflow Statement Ratios

Annual Quarterly TTM

Fiscal Year Period Ending	FY 2025 Dec 30, 2025	FY 2024 Dec 30, 2024	FY 2023 Dec 30, 2023	FY 2022 Dec 30, 2022	FY 2021 Dec 30, 2021	FY 2020 Dec 30, 2020
Net Income	-328.94M	-255.86M	-192.41M	-140.24M	-72.27M	-74.81M
Depreciation & Amortization	4.58M	4.35M	3.59M	5.88M	147K	720K
Stock-Based Compensation	46.08M	39.74M	30.62M	18.37M	11.69M	6.02M
Other Working Capital	10.52M	10.24M	6.63M	-1.61M	-731K	-4.87M
Other Non-Cash Items	5.82M	-7.62M	-6.87M	-3.39M	-343K	37.54M
Deferred Income Tax	n/a	n/a	n/a	n/a	n/a	n/a
Change in Working Capital	8.01M	11.6M	11.44M	751K	2.02M	-5.32M
Operating Cash Flow	-264.44M	-207.79M	-153.62M	-118.64M	-58.76M	-35.85M
Capital Expenditures	-1.55M	-573K	-2.8M	-6.86M	-1.72M	n/a
Cash Acquisitions	n/a	n/a	n/a	117.86K	n/a	n/a
Purchase of Investments	-687.17M	-255.6M	-348.8M	-177.86M	n/a	n/a
Sales Maturities Of Investments	289.2M	294.45M	253.78M	60M	n/a	n/a
Other Investing Acitivies	n/a	n/a	n/a	-117.86K	n/a	8.42M
Investing Cash Flow	-399.53M	38.28M	-97.82M	-124.72M	-1.72M	8.42M
Debt Repayment	215.13M	n/a	n/a	n/a	n/a	n/a
Common Stock Repurchased	n/a	n/a	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	-48.9M	1.12M	n/a	1.61M	-30K	560K
Financial Cash Flow	878.23M	214.45M	163.54M	163.56M	37.98M	232.2M
Net Cash Flow	214.26M	44.94M	-87.91M	-79.8M	-22.51M	204.77M
Free Cash Flow	-266M	-208.36M	-156.42M	-125.5M	-60.48M	-35.85M
Adj. Free Cash Flow	-312.08M	-248.1M	-187.04M	-143.87M	-72.17M	-41.87M
Maintenance CapEx	-1.55M	-573K	-2.8M	-6.86M	-1.72M	n/a
Growth CapEx	n/a	n/a	n/a	n/a	n/a	n/a
Owner Earnings	-266M	-208.36M	-156.42M	-125.5M	-60.48M	-35.85M